Verrica Pharmaceuticals Inc. (VRCA): Total Liabilities
$22.39M
As of 2025-12-31
$31.71M
As of 2026-06-30
+68.4%
3-year compound annual growth
-11.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.39M | -65.0% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $63.99M | +3.5% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $61.83M | n/m | 2025-03-11, Balance as of period end |
| 2022-12-31 | $4.69M | -90.1% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $47.52M | +15.4% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $41.17M | n/m | 2022-03-02, Balance as of period end |
| 2019-12-31 | $3.41M | +37.6% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $2.48M | +302.1% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $616.0K | n/a | 2019-03-07, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $22.39M | -65.0% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $7.04M | -0.3% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $6.64M | -34.4% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $41.92M | +370.4% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $11.64M | -0.5% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $189.25M | +45.1% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $306.60M | -7.0% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $18.08M | +2.4% |
Compare VRCA, ETST, SBFM, LIFD side by side · Screen every company in Pharmaceutical Preparations ↗